Clinical Trial Update: Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) [Phase 2]

View source ↗

Summary

Amgen completed a Phase 2 trial (AURORA) evaluating the safety and efficacy of avacopan in moderate-to-severe hidradenitis suppurativa; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Avacopan (avacopan)

Snippet

Sponsor: Amgen | Conditions: Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Status: COMPLETED | Results posted: 2024-03-15